MIRA INFORM REPORT

 

 

Report Date :

16.03.2012

 

IDENTIFICATION DETAILS

 

Name :

SRI KRISHNA PHARMACEUTICALS LIMITED

 

 

Registered Office :

C-4, Industrial Area, Uppal, Hyderabad – 500039, Andhra Pradesh.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

26.09.1974

 

 

Com. Reg. No.:

01-001790

 

 

Capital Investment / Paid-up Capital :

Rs.110.835 Millions

 

 

CIN No.:

[Company Identification No.]

U24230AP1974PLC001790

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDS01333D

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Active Pharmaceutical Ingredients (API’s), Direct Compression Granules, Drug Delivery Systems, Vitamins and Testicles.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 3000000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

 

 

 

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office/ Factory :

C-4, Industrial Area, Uppal, Hyderabad – 500039, Andhra Pradesh, India.

Tel. No.:

91-40-27201101-02/ 27200103/ 27204471-72

Fax No.:

91-40-27200103/ 27204470/ 27205432

E-Mail :

nsk@srikrishnapharma.com

vvs@srikrishnapharma.com

Website :

http://www.srikrishnapharma.com

 

 

DIRECTORS

 

(AS ON 23.09.2011)

 

Name :

Dr. Vempalli Venkata Subba Reddy

Designation :

Chairman

Address :

Plot No. 110, Road No. 4, Dhanalakshmi Colony, Mahendra Hills, East Maredpally, Secunderabad-500026, Andhra Pradesh, India.

Date of Birth/Age :

26.09.1942

Date of Appointment :

28.09.2010

DIN No.:

00626671

Other Directorship :

 

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230AP1974PLC001790

SRI KRISHNA PHARMACEUTICALS LIMITED

Whole-time director

28-09-10

26-09-74

-

Active

NO

2

L24110AP1985PLC005315

SRI KRISHNA DRUGS LIMITED

Managing director

01-08-08

18-02-85

-

Amalgamated

NO

3

U65910AP1990PTC011408

KELLTON SECURITIES PRIVATE LIMITED

Director

21-06-90

21-06-90

16-09-09

Active

NO

4

U24110AP1993PTC016704

SRI KRISHNA AGRI - FOODS PRIVATE LIMITED

Director

08-12-93

08-12-93

-

Active

NO

5

U67120AP1995PTC021208

KELLTON COMMODITY AND DERIVATIVES PRIVATE LIMITED

Director

26-07-95

26-07-95

22-01-10

Active

NO

6

U67120AP1995PTC021206

SRIPAD EQUITIES PRIVATE LIMITED

Director

26-07-95

26-07-95

-

Active

NO

7

U24120AP1995PTC021782

SRI KRISHNA BIOFERT PRIVATE LIMITED

Director

21-09-95

21-09-95

-

Active

NO

8

L24110AP1980PLC002633

PREMIER EXPLOSIVES LIMITED

Director

27-05-99

27-05-99

30-09-09

Active

NO

9

U72200AP2000PLC034518

ENSOLVIA INFOTECH LIMITED

Director

29-05-00

29-05-00

-

Active

NO

10

U72300TN2003PTC051618

PROPART SOLUTIONS INDIA PRIVATE LIMITED

Director

20-10-03

20-10-03

30-12-05

Active

NO

11

U85100TZ2011PTC017124

ISHA AROGYA PRIVATE LIMITED

Director

02-06-11

02-06-11

-

Active

NO

 

 

Name :

Mr. Vempalli Venkata Krishna Reddy

Designation :

Managing Director

Address :

3-33-39, Dhanalakshmi Colony, Mahendra Hills, East Maredpally, Secunderabad - 500026, Andhra Pradesh, India.

Date of Birth/Age :

31.08.1966

Date of Appointment :

15.10.1997

DIN No.:

00024216

Other Directorship :

 

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U67120AP1995PTC021208

KELLTON COMMODITY AND DERIVATIVES PRIVATE LIMITED

Director

26-07-95

26-07-95

22-01-10

Active

NO

2

U67120AP1995PTC021206

SRIPAD EQUITIES PRIVATE LIMITED

Director

26-07-95

26-07-95

-

Active

NO

3

U24120AP1995PTC021782

SRI KRISHNA BIOFERT PRIVATE LIMITED

Director

21-09-95

21-09-95

-

Active

NO

4

U65910AP1990PTC011408

KELLTON SECURITIES PRIVATE LIMITED

Director

11-10-97

11-10-97

16-09-09

Active

NO

5

U24230AP1974PLC001790

SRI KRISHNA PHARMACEUTICALS LIMITED

Managing director

28-09-10

15-10-97

-

Active

NO

6

L24110AP1985PLC005315

SRI KRISHNA DRUGS LIMITED

Director

04-06-98

04-06-98

-

Amalgamated

NO

7

U72200AP2000PLC034518

ENSOLVIA INFOTECH LIMITED

Director

29-05-00

29-05-00

-

Active

NO

 

 

Name :

Mr. Vempalli Satyavathi

Designation :

Director

Address :

Plot No. 110, Road No. 4, Dhanalakshmi Colony, Mahendra Hills, East Maredpally, Secunderabad-500026, Andhra Pradesh, India.

Date of Birth/Age :

18.03.1945

Date of Appointment :

13.12.1983

DIN No.:

00626709

Other Directorship :

 

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230AP1974PLC001790

SRI KRISHNA PHARMACEUTICALS LIMITED

Director

13-12-83

13-12-83

-

Active

NO

2

L24110AP1985PLC005315

SRI KRISHNA DRUGS LIMITED

Director

18-02-85

18-02-85

-

Amalgamated

NO

3

U65910AP1990PTC011408

KELLTON SECURITIES PRIVATE LIMITED

Director

21-06-90

21-06-90

16-09-09

Active

NO

4

U24110AP1993PTC016704

SRI KRISHNA AGRI - FOODS PRIVATE LIMITED

Director

08-12-93

08-12-93

-

Active

NO

5

U24120AP1995PTC021782

SRI KRISHNA BIOFERT PRIVATE LIMITED

Director

21-09-95

21-09-95

-

Active

NO

6

U72200AP2000PLC034518

ENSOLVIA INFOTECH LIMITED

Director

17-09-08

31-07-08

-

Active

NO

 

 

Name :

Mr. Chivukula Gopala Krishna Murty

Designation :

Director

Address :

7-B, Sanjeeva Reddy Nagar, Hyderabad-500038, Andhra Pradesh, India.

Date of Birth/Age :

16.01.1931

Date of Appointment :

06.05.1969

DIN No.:

00312700

Other Directorship :

 

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

L24110AP1985PLC005315

SRI KRISHNA DRUGS LIMITED

Director

18-02-85

18-02-85

-

Amalgamated

NO

2

U24230AP1974PLC001790

SRI KRISHNA PHARMACEUTICALS LIMITED

Director

06-05-89

06-05-89

-

Active

NO

3

U65910AP1990PTC011408

KELLTON SECURITIES PRIVATE LIMITED

Director

21-06-90

21-06-90

16-09-09

Active

NO

4

U24110AP1993PTC016704

SRI KRISHNA AGRI - FOODS PRIVATE LIMITED

Director

08-12-93

08-12-93

-

Active

NO

5

U24231TN1994PLC027491

NATCO ORGANICS LIMITED

Director

28-09-96

28-09-96

-

Active

NO

6

U24239AP1978PLC002276

GLAND PHARMA LIMITED

Director

30-08-04

30-08-04

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 23.09.2011)

 

Names of Shareholders

 

 

No. of Shares

 

 

 

Dr. V. V. Subba Reddy (IND)

 

1503000

C Ramakrishna Reddy

 

3500

V. Satyavathi

 

2430500

C Reddy Rani

 

3500

G Konida Reddy

 

11900

G.V. Subba Reddy

 

7000

Sunitha Reddy

 

550100

Vempalli Venkata Krishna Reddy

 

1752050

V. Shilpa

 

290300

V.V. Subba Reddy HUF

 

3033150

Hitesh Talreja

 

67

Jasu Parekh

 

200

Mayur Shah

 

67

Nidhi Parekh

 

267

 

 

(AS ON 30.09.2011)

Equity Shares Break – up

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

98.61

Other top fifty shareholders

 

1.01

Others

 

0.38

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of active pharmaceutical ingredients (API’s), Direct compression granules, drug delivery systems, vitamins and testicles.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         State Bank of India,

Overseas Branch, Jubilee Hills, Hyderabad - 500033, Andhra Pradesh, India

 

·         Syndicate Bank

N S Road, Hyderabad, Andhra Pradesh, India

 

 

Facilities :

Secured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

Rupee Term Loans Banks Secured

74.320

91.054

Rupee Term Loans Financial Institution Secured

163.231

5.100

Working Capital Loans Banks Secured

153.356

79.480

Working Capital Loans Other Secured

2.717

19.747

Hire Purchase Installment Payable Secured

0.000

0.787

 

 

 

Total

 

393.624

196.168

 

 

Unsecured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Loans Directors Unsecured

137.399

109.072

 

 

 

Total

 

137.399

109.072

 

 

 

Banking Relations :

--

 

 

Financial Institution :

·         A P State Financial Company

Chirag Ali Lane, ABIDS, Hyderabad, Andhra Pradesh, India

 

 

Auditors :

 

Name :

Tukaram and Company

Chartered Accountant

Address :

# 3-6-69, Flat No. 209, Venkatarama Towers, Basheerbagh, Hyderabad-500029, Andhra Pradesh, India.

Tel. No.:

91-40-23221536/ 23228785/ 23228086

Fax No.:

91-40-23221474

Pan No.:

AAAFT9960E

 

 

CAPITAL STRUCTURE

 

(AS ON 23.09.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11918455

Equity Shares

Rs.10/- each

Rs.119.185 Millions

 

 

 

 

 

 

(AS ON 31.03.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11083455

Equity Shares

Rs.10/- each

Rs.110.835 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

110.835

110.835

87.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

559.098

484.820

273.843

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

669.933

595.655

361.343

LOAN FUNDS

 

 

 

1] Secured Loans

393.624

196.168

104.111

2] Unsecured Loans

137.399

109.072

2.556

TOTAL BORROWING

531.023

305.240

106.667

DEFERRED TAX LIABILITIES

41.654

33.407

23.626

 

 

 

 

TOTAL

1242.610

934.302

491.636

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

525.960

470.525

236.524

Capital work-in-progress

27.213

2.359

0.000

 

 

 

 

INVESTMENT

0.383

0.446

0.006

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

463.129

358.392

183.614

 

Sundry Debtors

708.637

522.861

410.003

 

Cash & Bank Balances

55.851
96.036
29.782

 

Other Current Assets

0.000
0.000
0.000

 

Loans & Advances

178.205
179.244
68.363

Total Current Assets

1405.822

1156.533

691.762

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

512.923
478.531
353.773

 

Other Current Liabilities

133.167
103.363
13.786

 

Provisions

70.678
113.667
69.097

Total Current Liabilities

716.768

695.561

436.656

Net Current Assets

689.054

460.972

255.106

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1242.610

934.302

491.636

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

2442.511

2057.290

1428.909

 

 

Other Income

22.153

26.992

67.531

 

 

TOTAL                                     (A)

2464.664

2084.282

1496.440

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption Material Changes Inventories

1552.994

1231.850

927.234

 

 

Manufacturing Service Costs

204.599

167.258

87.591

 

 

Employees related Expenses

204.433

164.496

94.172

 

 

Administrative, Selling and Other Expenses

261.670

198.296

205.358

 

 

Prior Period Items 

0.712

0.615

0.025

 

 

TOTAL                                     (B)

2224.408

1762.515

1314.380

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

241.680

311.849

182.060

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

45.618

29.489

15.819

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

196.062

282.360

166.241

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

59.069

51.142

30.727

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

136.993

231.218

135.514

 

 

 

 

 

Less

TAX                                                                  (H)

48.910

86.386

49.506

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

88.083

144.832

86.008

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

398.966

277.036

173.656

 

 

 

 

 

Add

EXCESS PROVISION MADE IN INCOME TAX ON EARLIER YEAR WRITTEN BACK AND REFUNDS

0.047

0.005

0.587

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Final Dividend

11.918

17.500

8.750

 

 

Tax on Distributed Profits

1.934

2.906

1.487

 

 

Amount Transferred to General Reserve

2.500

2.500

2.500

 

BALANCE CARRIED TO THE B/S

470.744

398.967

247.514

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

1321.813

974.590

669.136

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

875.555

616.178

367.990

 

 

Capital Equipment

6.450

3.176

0.000

 

TOTAL IMPORTS

882.005

619.354

367.990

 

 

 

 

 

 

Earnings Per Share (Rs.)

7.95

13.07

9.90

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

3.57

6.95

5.75

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.61

11.24

9.48

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.09

14.21

14.60

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.20

0.39

0.38

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.86

1.68

1.50

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.96

1.66

1.58

 


 

LOCAL AGENCY FURTHER INFORMATION

 

REVIEW OF PERFORMANCES:

 

During the financial year under consideration 6803.03 MT’s of Paracetamol, 2782.92 MT’s of D C Granules and 55.91 MT’s of Domperidone were produced as against previous year’s production of 5860.43 MT’s Paracetamol, 1470.40 MT’s of D.C. Granules and 41.06 MT’s of Domperidone respectively. The company recorded a turnover of Rs.2420.398 Millions as against the previous year’s turnover of Rs. 2040.534 Millions

 

During the year the Company’s sales quantity of Paracetamol 6709.38 MT’s, D C Granules 2718.70 MT’s and Domperidone 55.74 MT’s as against the previous year Paracetamol sale quantity of 5879.43 MT’s, D C Granules 1456.83 MT’s and Domperidone 42.03 MT’s.

 

 

Bankers Charges Report as per Registry

 

This form is for

Modification of charge

Charge identification number of the modified 

90124330

Corporate identity number of the company

U24230AP1974PLC001790

Name of the company

SRI KRISHNA PHARMACEUTICALS LIMITED

Address of the registered office or of the principal place of  business in India of the company

C-4, Industrial Area, Uppal, Hyderabad-500039, Andhra Pradesh, India.

nsk@srikrishnapharma.com

Type of charge

Immovable Property as

Book Debts

Movable Property (not being pledge)

Particular of charge holder

State Bank of India,

Overseas Branch, Jubilee Hills, Hyderabad-500033, Andhra Pradesh, India.

Tummalapalli.sankar@sbi.co.in

Nature of description of the instrument creating or modifying the charge

1. Supplemental agreement of loan for increase in the overall limit

 

2. Supplemental agreement of hypothecation of goods and assets for increase in the overall limit

 

3. Memorandum of deposits for creation of further charge

 

Date of instrument Creating the charge

21.01.2012

Amount secured by the charge

Rs.1348.000 Millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

Rate of Interest

CC (Hypothecation)-4.75% above BR Present effective rate being 14.75%,Term Loan-I and Corporate Loan-6.50% above BR Present effective rate being 16.50%Term Loan-II - 4.75% above BR Present effective rate being 14.75%.

 

Terms of Repayment

Term Loan-11 of Rs 300.000 Millions shall be repayable in 54 Quarterly Installments.

 

Margin

1) Cash Credit - Raw Material (Domestic and Imported); Stocks-in-process; Finished Goods, Book Debts/ Receivables: 25%

2) EPC, LC  and BG: 10%

 

Extent and Operation of the charge

1)  i) WC ii) Corporate -primary- exclusive first charge (hypothecation) on current assets of the company.-collateral-  extension on first charge on fixed assets of the company  both present and future including EM of immovable properties.

 

2) Term Loan l and II- primary-exclusive first charge on fixed assets of the company both present and future including EM of immovable properties.-collateral- extension of charge on current assets of the company.

 

Short particulars of the property charged

Industrial Plot Bearing No. C-4 in S. No 581/1,582/2,582 and 583 situated at Industrial Estate Uppal Kalan, Uppal Mandal, Ranga Reddy, District Andhra Pradesh.

 

Industrial Plot Bearing No. A-35 admeasuring 4091.71 sq mts situated at Nacharam Village, Uppal Mandal, Ranga Reddy, District Andhra Pradesh.

 

Land admeasuring Ac.1.11 Gts situated at Industrial Estate, Uppal and Land admeasuring AC 1.21 Gts Industrial Estate, Uppal Kalan, Uppal Mandal, Ranga Reddy, District Andhra Pradesh.

 

Industrial Plot Bearing No.C-2 (a) in S. No 581/1,582/2,582 and 583 situated at Industrial Estate, Uppal Kalan, Uppal Mandal, Ran Industrial Plot Bearing No. C-1/2(A) situated at Industrial Estate, Uppal

 

IAgricultural Dry Land situated at S.No 57. Raikunta Village, Pedda Golconda Kalan, Shamshabad Mandal, Ranga Reddy, District Andhra Pradesh.

 

S.No 57, 17, 97 and 98, 98, 97/E, 98/E, 112 Shamshabad Mandal, Ranga Reddy, District Andhra Pradesh

 

S.No 31, 30, 7, 4, 6, 48, 29, Athevelly (V), Medchal Mandal, Ranga Reddy, District Andhra Pradesh

 

S.No 195, 155, 189 Thakkapali Village, Yacharam Mandal, Ranga Reddy, District Andhra Pradesh

 

TS/RS No. 64Serilingampally, Ranga Reddy, District Andhra Pradesh

 

S.No 296/07/10, Bollarum Village, Narsapur Taluq Medak ,District Andhra Pradesh

 

Particulars of the present modification 

Enhancement and renewal of overall banking facilities from Rs.1178.000 Millions to Rs.1348.000 Millions

 

 

FIXED ASSETS:

 

·         Land

·         Lease Land

·         Factory Buildings

·         Administrative Buildings

·         Plant and Machinery

·         Electrical Equipments

·         Workshop Equipments

·         Water Systems

·         Storage Systems

·         Computers

·         Furniture and Fixtures

·         Laboratory Equipments

·         Office Equipments

·         Air Conditioner

·         Vehicles

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.50.31

UK Pound

1

Rs.79.05

Euro

1

Rs.65.83

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.